Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Clinical trial NCT00171340 · COMPLETED
Trial details
- NCT number
- NCT00171340
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2010-02-01
- Enrollment
- 1065
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.